Joaquim José Coutinho Ferreira
AuthID: R-000-7JF
291
TITLE: Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study (Journal of Neurology, (2019), 266, 12, (3038-3046), 10.1007/s00415-019-09527-2) Full Text
AUTHORS: Carlo Colosimo; David Charles; Vijay P Misra; Pascal Maisonobe; Savary Om; Abdulnayef A.; Adatepe N.U.; Araujo Leite M.A.; Badarny S.; Bajenaru O.; Bares M.; Bejjani P.; Bergmans B.; Bhidayasiri R.; Bozic H.; Cardoso Costa F.E.; Carlstrom C.; Castelnovo G.; Chang M.H.; Chang Y.Y.; ...More
PUBLISHED: 2019, SOURCE: Journal of Neurology, VOLUME: 266, ISSUE: 12
AUTHORS: Carlo Colosimo; David Charles; Vijay P Misra; Pascal Maisonobe; Savary Om; Abdulnayef A.; Adatepe N.U.; Araujo Leite M.A.; Badarny S.; Bajenaru O.; Bares M.; Bejjani P.; Bergmans B.; Bhidayasiri R.; Bozic H.; Cardoso Costa F.E.; Carlstrom C.; Castelnovo G.; Chang M.H.; Chang Y.Y.; ...More
PUBLISHED: 2019, SOURCE: Journal of Neurology, VOLUME: 266, ISSUE: 12
292
TITLE: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study Full Text
AUTHORS: Carlo Colosimo; David Charles; Vijay P Misra; Pascal Maisonobe; Savary Om; Abdulnayef A.; Adatepe N.U.; Araujo Leite M.A.; Badarny S.; Bajenaru O.; Bares M.; Bejjani P.; Bergmans B.; Bhidayasiri R.; Bozic H.; Cardoso Costa F.E.; Carlstrom C.; Castelnovo G.; Chang M.H.; Chang Y.Y.; ...More
PUBLISHED: 2019, SOURCE: Journal of Neurology, VOLUME: 266, ISSUE: 12
AUTHORS: Carlo Colosimo; David Charles; Vijay P Misra; Pascal Maisonobe; Savary Om; Abdulnayef A.; Adatepe N.U.; Araujo Leite M.A.; Badarny S.; Bajenaru O.; Bares M.; Bejjani P.; Bergmans B.; Bhidayasiri R.; Bozic H.; Cardoso Costa F.E.; Carlstrom C.; Castelnovo G.; Chang M.H.; Chang Y.Y.; ...More
PUBLISHED: 2019, SOURCE: Journal of Neurology, VOLUME: 266, ISSUE: 12
293
TITLE: Comments on: ‘Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease – a randomized controlled trial’
AUTHORS: Simões, RM; Castro Caldas, A; Ferreira, JJ;
PUBLISHED: 2018, SOURCE: European Journal of Neurology, VOLUME: 25, ISSUE: 1
AUTHORS: Simões, RM; Castro Caldas, A; Ferreira, JJ;
PUBLISHED: 2018, SOURCE: European Journal of Neurology, VOLUME: 25, ISSUE: 1
294
TITLE: Comments on: "Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial'
AUTHORS: Simoes, RM; Caldas, AC; Ferreira, JJ;
PUBLISHED: 2018, SOURCE: EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 25, ISSUE: 1
AUTHORS: Simoes, RM; Caldas, AC; Ferreira, JJ;
PUBLISHED: 2018, SOURCE: EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 25, ISSUE: 1
INDEXED IN:
WOS

IN MY:
ORCID

295
TITLE: Quality and reporting of guidelines on the diagnosis and management of dystonia Full Text
AUTHORS: Tamas, G; Abrantes, C; Valadas, A; Radics, P; Albanese, A; Tijssen, MAJ; Ferreira, JJ;
PUBLISHED: 2018, SOURCE: EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 25, ISSUE: 2
AUTHORS: Tamas, G; Abrantes, C; Valadas, A; Radics, P; Albanese, A; Tijssen, MAJ; Ferreira, JJ;
PUBLISHED: 2018, SOURCE: EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 25, ISSUE: 2
296
TITLE: Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis Full Text
AUTHORS: Caldeira, D; Rodrigues, FB; Duarte, MM; Sterrantino, C; Barra, M; Goncalves, N; Pinto, FJ; Ferreira, JJ; Costa, J;
PUBLISHED: 2018, SOURCE: DRUG SAFETY, VOLUME: 41, ISSUE: 1
AUTHORS: Caldeira, D; Rodrigues, FB; Duarte, MM; Sterrantino, C; Barra, M; Goncalves, N; Pinto, FJ; Ferreira, JJ; Costa, J;
PUBLISHED: 2018, SOURCE: DRUG SAFETY, VOLUME: 41, ISSUE: 1
297
TITLE: Influenza vaccination and prevention of cardiovascular disease mortality
AUTHORS: Caldeira, D; Ferreira, JJ; Costa, J;
PUBLISHED: 2018, SOURCE: LANCET, VOLUME: 391, ISSUE: 10119
AUTHORS: Caldeira, D; Ferreira, JJ; Costa, J;
PUBLISHED: 2018, SOURCE: LANCET, VOLUME: 391, ISSUE: 10119
INDEXED IN:
WOS

IN MY:
ORCID

298
TITLE: The launch of opicapone for Parkinson's disease: negatives versus positives
AUTHORS: Caldas, AC; Teodoro, T; Ferreira, JJ;
PUBLISHED: 2018, SOURCE: EXPERT OPINION ON DRUG SAFETY, VOLUME: 17, ISSUE: 3
AUTHORS: Caldas, AC; Teodoro, T; Ferreira, JJ;
PUBLISHED: 2018, SOURCE: EXPERT OPINION ON DRUG SAFETY, VOLUME: 17, ISSUE: 3
299
TITLE: What is Functional Mobility Applied to Parkinson's Disease?
AUTHORS: Bouca Machado, R; Maetzler, W; Ferreira, JJ;
PUBLISHED: 2018, SOURCE: JOURNAL OF PARKINSONS DISEASE, VOLUME: 8, ISSUE: 1
AUTHORS: Bouca Machado, R; Maetzler, W; Ferreira, JJ;
PUBLISHED: 2018, SOURCE: JOURNAL OF PARKINSONS DISEASE, VOLUME: 8, ISSUE: 1
300
TITLE: Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study
AUTHORS: Caldeira, D; Rodrigues, R; Abreu, D; Anes, AM; Rosa, MM; Ferreira, JJ;
PUBLISHED: 2018, SOURCE: EXPERT OPINION ON DRUG SAFETY, VOLUME: 17, ISSUE: 4
AUTHORS: Caldeira, D; Rodrigues, R; Abreu, D; Anes, AM; Rosa, MM; Ferreira, JJ;
PUBLISHED: 2018, SOURCE: EXPERT OPINION ON DRUG SAFETY, VOLUME: 17, ISSUE: 4